No CrossRef data available.
Published online by Cambridge University Press: 15 April 2020
Metabolic abnormalities are commonly associated with antipsychotics treatment and may increase prevalence of cardiovascular disorders. There are some reports that electroconvulsive therapy (ECT) may reduce weight in depressed patients.
The study is aimed at comparing metabolic safety of combination of ECT and antipsychotics with antipsychotics alone in schizophrenia.
Weight, abdominal circumference, body mass index (BMI), fasting plasma levels of cholesterol, HDL, LDL, triglycerides, glucose, blood pressure (BP) were recorded for 12 schizophrenic subjects (4W and 8M, age 29.2±9.4 year) before (pre-ECT) and after (post-ECT) 12 to 15 bilateral ECT sessions combined with antipsychotics treatment. These were compared with data for 44 schizophrenic subjects (25W and 19M, age 35.7±13.8 year) collected before (pre-AP) and after (post-AP) in-hospital antipsychotics treatment.
Our results might indicate that bilateral ECT neither improves nor worsens metabolic parameters in subjects with schizophrenia treated with antipsychotics.
Comments
No Comments have been published for this article.